Procept Biorobotics Corp (PRCT) Stock Price, Quote & News

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 232 7200

Website: www.procept-biorobotics.com

Address:

150 Baytech Drive, San Jose, United States

BillionerOfKing Jan. 30 at 3:35 PM

$PRCT Current Stock Price: $28.94 Contracts to trade: $30 PRCT Feb 20 2026 Call Entry: $1.05 Exit: $1.77 ROI: 68% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Magic8BallResponse Jan. 25 at 5:17 PM

$PRCT New management to take advantage of prostate cancer opportunity...... Hurry up and buy!!!!

1 · Reply

Dietl Jan. 23 at 7:55 PM

$PRCT BSX needs to buy this at $50 and free all the souls here from torment

0 · Reply

Dietl Jan. 15 at 8:22 PM

$PRCT yeah it is shit

0 · Reply

Dietl Jan. 14 at 3:32 PM

$PRCT what happened here?

0 · Reply

Stonkleader55 Jan. 13 at 9:17 PM

$PRCT this is a dogshit investment so far, what is going on?

1 · Reply

JackDarwin Jan. 6 at 1:16 PM

$PRCT Bullish Above the Stomach Candlestick Pattern Formed at Downtrend

0 · Reply

EcosystemEquity Dec. 24 at 11:08 AM

$PRCT Forward visibility remains uneven as execution velocity aligns with stated operational milestones. Failure to demonstrate progress would likely keep valuation capped.

0 · Reply

ARMRreport Dec. 19 at 7:23 PM

Hot off the press... The 2026 Medical Robotics Landscape: Industrialization & Integration #StocksToWatch $ISRG $GMED $RXRX $TEM $PRCT https://armrinvesting.substack.com/publish/post/182114397?utm_campaign=post-expanded-share&utm_medium=web #investing

0 · Reply

JarvisFlow Dec. 18 at 3:51 PM

Truist Securities has adjusted their stance on PROCEPT BioRobotics ( $PRCT ), setting the rating to Buy with a target price of 50 → 47.

0 · Reply

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

Dec 24, 2025, 8:30 AM EST - 5 weeks ago

Where To Invest In 2026: Top 5 Secular Growth Trends

AMPX CHYM GH LSCC MOD

Nov 20, 2025, 4:03 PM EST - 2 months ago

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Nov 20, 2025, 8:40 AM EST - 2 months ago

Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits

BA BFAM CWAN EPS EW LSCC MOD

Nov 4, 2025, 9:36 PM EST - 3 months ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:03 PM EST - 3 months ago

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

Oct 15, 2025, 4:03 PM EDT - 3 months ago

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 6, 2025, 12:30 PM EDT - 4 months ago

Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader

Aug 14, 2025, 5:24 PM EDT - 6 months ago

Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy

Aug 7, 2025, 2:17 AM EDT - 6 months ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:03 PM EDT - 6 months ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jul 24, 2025, 6:00 PM EDT - 6 months ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Jul 23, 2025, 8:00 AM EDT - 6 months ago

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

Jul 21, 2025, 4:03 PM EDT - 7 months ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 14, 2025, 9:15 PM EDT - 7 months ago

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

May 17, 2025, 7:00 AM EDT - 9 months ago

19 stocks at the intersection of AI and robotics that could see big sales boosts

AI AMBA CLS HSAI IOT ISRG NOW

Apr 29, 2025, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

Apr 24, 2025, 4:03 PM EDT - 10 months ago

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Apr 24, 2025, 2:37 PM EDT - 10 months ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 7:00 AM EDT - 10 months ago

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Apr 10, 2025, 4:03 PM EDT - 10 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Mar 24, 2025, 8:00 AM EDT - 11 months ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Mar 14, 2025, 8:00 AM EDT - 11 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Mar 11, 2025, 4:42 AM EDT - 11 months ago

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

Feb 25, 2025, 4:02 PM EST - 1 year ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 8:00 AM EST - 1 year ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Jan 16, 2025, 9:00 AM EST - 1 year ago

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

Nov 26, 2024, 4:05 PM EST - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Nov 26, 2024, 5:10 AM EST - 1 year ago

Procept BioRobotics: Continued Growth Runway Ahead

Oct 29, 2024, 8:43 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

Oct 28, 2024, 4:19 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Oct 28, 2024, 2:17 PM EDT - 1 year ago

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

Oct 28, 2024, 10:32 AM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Oct 9, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 7, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

Aug 28, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 21, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Aug 3, 2024, 9:23 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

Jul 15, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

Jun 17, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

Jun 3, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

May 13, 2024, 4:05 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 6, 2024, 8:00 AM EDT - 1 year ago

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 1, 2024, 12:56 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

May 1, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Apr 23, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Apr 4, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

BillionerOfKing Jan. 30 at 3:35 PM

0 · Reply

Magic8BallResponse Jan. 25 at 5:17 PM

$PRCT New management to take advantage of prostate cancer opportunity...... Hurry up and buy!!!!

1 · Reply

Dietl Jan. 23 at 7:55 PM

$PRCT BSX needs to buy this at $50 and free all the souls here from torment

0 · Reply

Dietl Jan. 15 at 8:22 PM

$PRCT yeah it is shit

0 · Reply

Dietl Jan. 14 at 3:32 PM

$PRCT what happened here?

0 · Reply

Stonkleader55 Jan. 13 at 9:17 PM

$PRCT this is a dogshit investment so far, what is going on?

1 · Reply

JackDarwin Jan. 6 at 1:16 PM

$PRCT Bullish Above the Stomach Candlestick Pattern Formed at Downtrend

0 · Reply

EcosystemEquity Dec. 24 at 11:08 AM

$PRCT Forward visibility remains uneven as execution velocity aligns with stated operational milestones. Failure to demonstrate progress would likely keep valuation capped.

0 · Reply

ARMRreport Dec. 19 at 7:23 PM

0 · Reply

JarvisFlow Dec. 18 at 3:51 PM

Truist Securities has adjusted their stance on PROCEPT BioRobotics ( $PRCT ), setting the rating to Buy with a target price of 50 → 47.

0 · Reply

Muddymac Dec. 16 at 10:08 PM

$PRCT I like this company a lot, but be prepared for a rough patch until mid-‘26. I think they will struggle a bit this quarter and next getting sales and marketing back on track. Be ready to buy the dips.

0 · Reply

JarvisFlow Dec. 12 at 4:12 PM

UBS updates rating for PROCEPT BioRobotics ( $PRCT ) to Buy, target set at 62.

0 · Reply

aristocks Dec. 11 at 6:15 PM

$SYM and $PRCT are my robotics play! With now the government talking about robotics AND the FED money printing starting tomorrow for the next 6-7 months (to bail out AI and Scam Altm@n - ops sorry Sam), liquidity will flood the market, and hopefully big institutions (the one getting all the money printing) will start buying up! Only sad part, everyday Joes and Janes will keep suffering.. because the current FED and ADMIN instead of helping avg Americans, again choosing to help BIG companies.. but hey... it is, what it is..

2 · Reply